{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T11:33:28Z","timestamp":1788608008843,"version":"build-2803163510"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>With advancements in healthcare services, there has been an increase in the population of immunosuppressed patients and the frequency of opportunistic pathogens including rare yeasts (RY). We aimed to provide data on the distribution of RY causing invasive infections and their antifungal susceptibility profiles. In this retrospective study, the distribution of RYs obtained between January 2015 and January 2023 examined. Antifungal susceptibility analyses of the isolates conducted using the broth microdilution method following European Committee on Antimicrobial Susceptibility Testing (EUCAST) recommendations. The patients\u2019 demographics, predisposing factors and outcomes were investigated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 15 species were identified from 56 clinical samples, including\n                      <jats:italic>Clavispora lusitaniae<\/jats:italic>\n                      ,\n                      <jats:italic>Kluyveromyces marxianus<\/jats:italic>\n                      ,\n                      <jats:italic>Magnusiomyces capitatus<\/jats:italic>\n                      ,\n                      <jats:italic>Wickerhamomyces anomalus<\/jats:italic>\n                      ,\n                      <jats:italic>Meyerozyma guilliermondii<\/jats:italic>\n                      ,\n                      <jats:italic>Magnusiomyces clavatus<\/jats:italic>\n                      ,\n                      <jats:italic>Candida dubliniensis<\/jats:italic>\n                      ,\n                      <jats:italic>Rhodotorula mucilaginosa<\/jats:italic>\n                      ,\n                      <jats:italic>Cyberlindnera jadinii<\/jats:italic>\n                      ,\n                      <jats:italic>Pichia inconspicua<\/jats:italic>\n                      ,\n                      <jats:italic>Candida auris<\/jats:italic>\n                      ,\n                      <jats:italic>Yarrowia lipolytica<\/jats:italic>\n                      ,\n                      <jats:italic>Trichosporon asahii<\/jats:italic>\n                      ,\n                      <jats:italic>Wickerhamiella pararugosa<\/jats:italic>\n                      and\n                      <jats:italic>Saccharomyces cerevisiae<\/jats:italic>\n                      . Observed highly heterogenous antifungal susceptibility results depending on the species. Admission to the intensive care unit (ICU), being 65 years or older, and neutropenia increased mortality. Fourteen-day and 30-day mortality rates were 27.8% and 35.2%, respectively.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The variability of RY encountered in various centers and differences in antifungal susceptibility profiles warrant further research on this topic, both regionally and globally.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12866-025-04016-1","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:03:42Z","timestamp":1751414622000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Epidemiology and antifungal susceptibilities of rare yeast infections in a tertiary care center"],"prefix":"10.1186","volume":"25","author":[{"given":"Berire","family":"Yavuz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6zge","family":"Turhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6zlem Koyuncu","family":"\u00d6zyurt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6zg\u00fcl","family":"\u00c7etinkaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c7a\u011flayan Merve","family":"Ayaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betil","family":"\u00d6zhak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Latife","family":"Mam\u0131ko\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"issue":"2","key":"4016_CR1","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/S1473-3099(10)70218-8","volume":"11","author":"MH Miceli","year":"2011","unstructured":"Miceli MH, Diaz JA, Lee SA. Emerging opportunistic yeast infections. Lancet Infect Dis. 2011;11(2):142\u201351.","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"4016_CR2","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.idc.2021.03.007","volume":"35","author":"TP McCarty","year":"2021","unstructured":"McCarty TP, White CM, Pappas PG. Candidemia and invasive candidiasis. Infect Dis Clin N Am. 2021;35(2):389\u2013413.","journal-title":"Infect Dis Clin N Am"},{"issue":"4","key":"4016_CR3","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1007\/s42770-022-00813-2","volume":"53","author":"R Ghasemi","year":"2022","unstructured":"Ghasemi R, Lotfali E, Rezaei K, Madinehzad SA, Tafti MF, Aliabadi N, et al. Meyerozyma guilliermondii species complex: review of current epidemiology, antifungal resistance, and mechanisms. Braz J Microbiol. 2022;53(4):1761\u201379.","journal-title":"Braz J Microbiol"},{"issue":"5","key":"4016_CR4","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1086\/506573","volume":"43","author":"B Sendid","year":"2006","unstructured":"Sendid B, Lacroix C, Bougnoux ME. Is Candida Kefyr an emerging pathogen in patients with oncohematological diseases? Clin Infect Dis. 2006;43(5):666\u20137.","journal-title":"Clin Infect Dis"},{"key":"4016_CR5","doi-asserted-by":"crossref","unstructured":"Apsemidou A, Fuller MA, Idelevich EA, Kurzai O, Tragiannidis A, Groll AH. Candida lusitaniae breakthrough fungemia in an Immuno-Compromised adolescent: case report and review of the literature. J fungi (Basel Switzerland). 2020;6(4).","DOI":"10.3390\/jof6040380"},{"issue":"3","key":"4016_CR6","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1086\/380643","volume":"38","author":"R Martino","year":"2004","unstructured":"Martino R, Salavert M, Parody R, Tomas JF, de la Camara R, Vazquez L, et al. Blastoschizomyces capitatus infection in patients with leukemia: report of 26 cases. Clin Infect Dis. 2004;38(3):335\u201341.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"4016_CR7","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1086\/502583","volume":"26","author":"AC Pasqualotto","year":"2005","unstructured":"Pasqualotto AC, Sukiennik TC, Severo LC, de Amorim CS, Colombo AL. An outbreak of Pichia anomala fungemia in a Brazilian pediatric intensive care unit. Infect Control Hosp Epidemiol. 2005;26(6):553\u20138.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"4","key":"4016_CR8","doi-asserted-by":"publisher","first-page":"e0159421","DOI":"10.1128\/mBio.01594-21","volume":"12","author":"R Sprute","year":"2021","unstructured":"Sprute R, Cornely OA, Chen SC, Seidel D, Schuetz AN, Zhang SX. All you need to know and more about the diagnosis and management of rare yeast infections. mBio. 2021;12(4):e0159421.","journal-title":"mBio"},{"issue":"42","key":"4016_CR9","doi-asserted-by":"publisher","first-page":"e7830","DOI":"10.1097\/MD.0000000000007830","volume":"96","author":"Y Yang","year":"2017","unstructured":"Yang Y, Guo F, Kang Y, Zang B, Cui W, Qin B, et al. Epidemiology, clinical characteristics, and risk factors for mortality of early- and late-onset invasive candidiasis in intensive care units in China. Med (Baltim). 2017;96(42):e7830.","journal-title":"Med (Baltim)"},{"key":"4016_CR10","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.2147\/IDR.S173805","volume":"11","author":"M Xiao","year":"2018","unstructured":"Xiao M, Chen SC, Kong F, Fan X, Cheng JW, Hou X, et al. Five-year China hospital invasive fungal surveillance net (CHIF-NET) study of invasive fungal infections caused by noncandidal yeasts: species distribution and Azole susceptibility. Infect Drug Resist. 2018;11:1659\u201367.","journal-title":"Infect Drug Resist"},{"issue":"3","key":"4016_CR11","doi-asserted-by":"publisher","first-page":"e124","DOI":"10.1111\/j.1439-0507.2011.02165.x","volume":"55","author":"AF Schmalreck","year":"2012","unstructured":"Schmalreck AF, Willinger B, Haase G, Blum G, Lass-Fl\u00f6rl C, Fegeler W, et al. Species and susceptibility distribution of 1062 clinical yeast isolates to Azoles, echinocandins, Flucytosine and amphotericin B from a multi-centre study. Mycoses. 2012;55(3):e124\u201337.","journal-title":"Mycoses"},{"issue":"9","key":"4016_CR12","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1093\/jac\/dkz231","volume":"74","author":"A Perez-Hansen","year":"2019","unstructured":"Perez-Hansen A, Lass-Florl C, Lackner M, Rare Yeast Study G. Antifungal susceptibility profiles of rare ascomycetous yeasts. J Antimicrob Chemother. 2019;74(9):2649\u201356.","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"4016_CR13","doi-asserted-by":"publisher","first-page":"115915","DOI":"10.1016\/j.diagmicrobio.2023.115915","volume":"106","author":"O Kucukoglu","year":"2023","unstructured":"Kucukoglu O, Sariguzel FM, Koc AN, Parkan OM. Molecular epidemiology, virulence factors, and antifungal susceptibility of Candida inconspicua strains isolated from clinical samples in Turkey. Diagn Microbiol Infect Dis. 2023;106(1):115915.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"4016_CR14","doi-asserted-by":"crossref","unstructured":"Noni M, Stathi A, Velegraki A, Malamati M, Kalampaliki A, Zachariadou L et al. Rare invasive yeast infections in Greek neonates and children, a retrospective 12-Year study. J fungi (Basel Switzerland). 2020;6(4).","DOI":"10.3390\/jof6040194"},{"issue":"1","key":"4016_CR15","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1186\/s12879-023-08477-5","volume":"23","author":"J Koleri","year":"2023","unstructured":"Koleri J, Petkar HM, Rahman SASHA, Rahman SAMA. Candida auris blood stream infection- a descriptive study from Qatar. BMC Infect Dis. 2023;23(1):513.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"4016_CR16","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1186\/s12879-020-05543-0","volume":"20","author":"J Chen","year":"2020","unstructured":"Chen J, Tian S, Han X, Chu Y, Wang Q, Zhou B, et al. Is the Superbug fungus really so scary? A systematic review and meta-analysis of global epidemiology and mortality of Candida auris. BMC Infect Dis. 2020;20(1):827.","journal-title":"BMC Infect Dis"},{"key":"4016_CR17","unstructured":"Method for the Determination of Broth Dilution Minimum Inhibitory Concentrations of Antifungal Agents for Yeasts, Version 7.3.2. [Internet]. 2020. Available from: https:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/AFST\/Files\/EUCAST_E_Def_7.3.2_Yeast_testing_definitive_revised_2020.pdf"},{"key":"4016_CR18","doi-asserted-by":"crossref","unstructured":"Astvad KMT, Arikan-Akdagli S, Arendrup MC. A pragmatic approach to susceptibility classification of yeasts without EUCAST clinical breakpoints. J Fungi (Basel). 2022;8(2).","DOI":"10.3390\/jof8020141"},{"issue":"7","key":"4016_CR19","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1007\/s10096-020-04147-5","volume":"40","author":"S Alp","year":"2021","unstructured":"Alp S, Gulmez D, Kardas RC, Karahan G, Tas Z, Gursoy G, et al. Expect the unexpected: fungemia caused by uncommon Candida species in a Turkish university hospital. Eur J Clin Microbiol Infect Dis. 2021;40(7):1539\u201345.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"4016_CR20","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1128\/JCM.39.1.339-342.2001","volume":"39","author":"F Peyron","year":"2001","unstructured":"Peyron F, Favel A, Michel-Nguyen A, Gilly M, Regli P, Bolmstrom A. Improved detection of amphotericin B-resistant isolates of Candida lusitaniae by etest. J Clin Microbiol. 2001;39(1):339\u201342.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"4016_CR21","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1128\/JCM.41.1.78-83.2003","volume":"41","author":"MA Pfaller","year":"2003","unstructured":"Pfaller MA, Diekema DJ, Messer SA, Boyken L, Hollis RJ, Jones RN, et al. In vitro activities of voriconazole, posaconazole, and four licensed systemic antifungal agents against Candida species infrequently isolated from blood. J Clin Microbiol. 2003;41(1):78\u201383.","journal-title":"J Clin Microbiol"},{"issue":"10","key":"4016_CR22","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.1128\/JCM.00942-09","volume":"47","author":"DJ Diekema","year":"2009","unstructured":"Diekema DJ, Messer SA, Boyken LB, Hollis RJ, Kroeger J, Tendolkar S, et al. In vitro activity of seven systemically active antifungal agents against a large global collection of rare Candida species as determined by CLSI broth microdilution methods. J Clin Microbiol. 2009;47(10):3170\u20137.","journal-title":"J Clin Microbiol"},{"issue":"2","key":"4016_CR23","doi-asserted-by":"publisher","first-page":"101236","DOI":"10.1016\/j.mycmed.2021.101236","volume":"32","author":"A Spiliopoulou","year":"2022","unstructured":"Spiliopoulou A, Kolonitsiou F, Vrioni G, Tsoupra S, Lekkou A, Paliogianni F. Invasive Candida Kefyr infection presenting as pyelonephritis in an ICU hospitalized COVID-19 patient: case report and review of the literature. J Mycol Med. 2022;32(2):101236.","journal-title":"J Mycol Med"},{"issue":"1","key":"4016_CR24","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1017\/S0950268817002643","volume":"146","author":"MB Tanabe","year":"2018","unstructured":"Tanabe MB, Patel SA. Blastoschizomyces capitatus pulmonary infections in immunocompetent patients: case report, case series and literature review. Epidemiol Infect. 2018;146(1):58\u201364.","journal-title":"Epidemiol Infect"},{"issue":"2","key":"4016_CR25","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s15010-014-0668-3","volume":"43","author":"S Mazzocato","year":"2015","unstructured":"Mazzocato S, Marchionni E, Fothergill AW, Sutton DA, Staffolani S, Gesuita R, et al. Epidemiology and outcome of systemic infections due to saprochaete capitata: case report and review of the literature. Infection. 2015;43(2):211\u20135.","journal-title":"Infection"},{"issue":"2","key":"4016_CR26","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.mycmed.2017.01.014","volume":"27","author":"C Cavanna","year":"2017","unstructured":"Cavanna C, Lallitto F, Mangione F, Tamarozzi F, Marone P, Ceriana P. Fungemia due to saprochaete capitata in a non-neutropenic patient hospitalized in an intensive care unit after cardiac surgery. J Med Mycol. 2017;27(2):281\u20134.","journal-title":"J Med Mycol"},{"issue":"4","key":"4016_CR27","first-page":"307","volume":"39","author":"G Brunetti","year":"2016","unstructured":"Brunetti G, Visconti V, Ghezzi MC, Mantovani S, Ferretti G, Raponi G. Management and treatment of Magnusiomyces capitatus (Geotrichum capitatum) pleural infection in a non-neutropenic patient with posaconazole. A new therapeutic opportunity? New Microbiol. 2016;39(4):307\u20139.","journal-title":"New Microbiol"},{"key":"4016_CR28","doi-asserted-by":"publisher","first-page":"107370","DOI":"10.1016\/j.ijid.2024.107370","volume":"151","author":"C Gibert","year":"2025","unstructured":"Gibert C, Wan M, Arsicot M, Huvelle U, Penhoat T, Koumar Y, et al. Mycotic aneurysm due to Magnusiomyces capitatus complicating a second liver transplant in a colonized patient. Int J Infect Dis. 2025;151:107370.","journal-title":"Int J Infect Dis"},{"issue":"2","key":"4016_CR29","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1093\/mmy\/myw055","volume":"55","author":"M Fernandez-Ruiz","year":"2017","unstructured":"Fernandez-Ruiz M, Guinea J, Puig-Asensio M, Zaragoza O, Almirante B, Cuenca-Estrella M, et al. Fungemia due to rare opportunistic yeasts: data from a population-based surveillance in Spain. Med Mycol. 2017;55(2):125\u201336.","journal-title":"Med Mycol"},{"issue":"7","key":"4016_CR30","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1093\/mmy\/myy133","volume":"57","author":"MC Esposto","year":"2019","unstructured":"Esposto MC, Prigitano A, Lo Cascio G, Ossi C, Grancini A, Cavanna C, et al. Yeast-like filamentous fungi: molecular identification and in vitro susceptibility study. Med Mycol. 2019;57(7):909\u201313.","journal-title":"Med Mycol"},{"key":"4016_CR31","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.3389\/fmicb.2019.02196","volume":"10","author":"V Buchta","year":"2019","unstructured":"Buchta V, Bolehovsk\u00e1 R, Hovorkov\u00e1 E, Cornely OA, Seidel D, \u017d\u00e1k P. Saprochaete clavata invasive Infections - A new threat to Hematological-Oncological patients. Front Microbiol. 2019;10:2196.","journal-title":"Front Microbiol"},{"key":"4016_CR32","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.mmcr.2016.03.001","volume":"11","author":"S Favre","year":"2016","unstructured":"Favre S, Rougeron A, Levoir L, P\u00e9rard B, Milpied N, Accoceberry I, et al. Saprochaete clavata invasive infection in a patient with severe aplastic anemia: efficacy of voriconazole and liposomal amphotericin B with adjuvant granulocyte transfusions before neutrophil recovery following allogeneic bone marrow transplantation. Med Mycol Case Rep. 2016;11:21\u20133.","journal-title":"Med Mycol Case Rep"},{"key":"4016_CR33","doi-asserted-by":"crossref","unstructured":"Kaplan E, Al-Hatmi AMS, Ilkit M, van den Gerrits AHG, Hagen F, Meis JF et al. Molecular diagnostics of arthroconidial yeasts, frequent pulmonary opportunists. J Clin Microbiol. 2018;56(1).","DOI":"10.1128\/JCM.01427-17"},{"issue":"2","key":"4016_CR34","doi-asserted-by":"publisher","first-page":"e0183421","DOI":"10.1128\/aac.01834-21","volume":"66","author":"J Noster","year":"2022","unstructured":"Noster J, Koeppel MB, Desnos-Olivier M, Aigner M, Bader O, Dichtl K, et al. Bloodstream infections caused by Magnusiomyces capitatus and Magnusiomyces clavatus: epidemiological, clinical, and Microbiological features of two emerging yeast species. Antimicrob Agents Chemother. 2022;66(2):e0183421.","journal-title":"Antimicrob Agents Chemother"},{"key":"4016_CR35","doi-asserted-by":"crossref","unstructured":"Desnos-Ollivier M, Lortholary O, Bretagne S, Dromer F. Azole susceptibility profiles of more than 9,000 clinical yeast isolates belonging to 40 common and rare species. Antimicrob Agents Chemother. 2021;65(6).","DOI":"10.1128\/AAC.02615-20"},{"issue":"4","key":"4016_CR36","doi-asserted-by":"publisher","first-page":"639","DOI":"10.3324\/haematol.11149","volume":"93","author":"N Kabbara","year":"2008","unstructured":"Kabbara N, Lacroix C, Peffault de Latour R, Socie G, Ghannoum M, Ribaud P, Breakthrough C. Parapsilosis and C. guilliermondii blood stream infections in allogeneic hematopoietic stem cell transplant recipients receiving long-term Caspofungin therapy. Haematologica. 2008;93(4):639\u201340.","journal-title":"Haematologica"},{"issue":"7","key":"4016_CR37","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1093\/mmy\/myaa005","volume":"58","author":"AA Stavrou","year":"2020","unstructured":"Stavrou AA, Perez-Hansen A, Lackner M, Lass-Florl C, Boekhout T. Elevated minimum inhibitory concentrations to antifungal drugs prevail in 14 rare species of candidemia-causing Saccharomycotina yeasts. Med Mycol. 2020;58(7):987\u201395.","journal-title":"Med Mycol"},{"issue":"10","key":"4016_CR38","doi-asserted-by":"publisher","first-page":"3551","DOI":"10.1128\/JCM.00865-06","volume":"44","author":"MA Pfaller","year":"2006","unstructured":"Pfaller MA, Diekema DJ, Mendez M, Kibbler C, Erzsebet P, Chang SC, et al. Candida guilliermondii, an opportunistic fungal pathogen with decreased susceptibility to fluconazole: geographic and Temporal trends from the ARTEMIS DISK antifungal surveillance program. J Clin Microbiol. 2006;44(10):3551\u20136.","journal-title":"J Clin Microbiol"},{"issue":"9","key":"4016_CR39","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1097\/00006454-200109000-00004","volume":"20","author":"PA Arag\u00e3o","year":"2001","unstructured":"Arag\u00e3o PA, Oshiro IC, Manrique EI, Gomes CC, Matsuo LL, Leone C, et al. Pichia anomala outbreak in a nursery: exogenous source? Pediatr Infect Dis J. 2001;20(9):843\u20138.","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"4016_CR40","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jinf.2011.11.002","volume":"64","author":"MN Chitasombat","year":"2012","unstructured":"Chitasombat MN, Kofteridis DP, Jiang Y, Tarrand J, Lewis RE, Kontoyiannis DP. Rare opportunistic (non-Candida, non-Cryptococcus) yeast bloodstream infections in patients with cancer. J Infect. 2012;64(1):68\u201375.","journal-title":"J Infect"},{"issue":"6","key":"4016_CR41","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.jmii.2012.07.013","volume":"46","author":"HC Lin","year":"2013","unstructured":"Lin HC, Lin HY, Su BH, Ho MW, Ho CM, Lee CY, et al. Reporting an outbreak of Candida pelliculosa fungemia in a neonatal intensive care unit. J Microbiol Immunol Infect. 2013;46(6):456\u201362.","journal-title":"J Microbiol Immunol Infect"},{"issue":"6","key":"4016_CR42","doi-asserted-by":"publisher","first-page":"e0296522","DOI":"10.1128\/spectrum.02965-22","volume":"10","author":"SS Jean","year":"2022","unstructured":"Jean SS, Yang HJ, Hsieh PC, Huang YT, Ko WC, Hsueh PR. In vitro susceptibilities of worldwide isolates of intrapulmonary Aspergillus species and important Candida species in sterile body sites against important antifungals: data from the antimicrobial testing leadership and surveillance program, 2017\u20132020. Microbiol Spectr. 2022;10(6):e0296522.","journal-title":"Microbiol Spectr"},{"issue":"8","key":"4016_CR43","doi-asserted-by":"publisher","first-page":"795","DOI":"10.3109\/13693786.2013.807444","volume":"51","author":"J Guitard","year":"2013","unstructured":"Guitard J, Angoulvant A, Letscher-Bru V, L\u2019Ollivier C, Cornet M, Dalle F, et al. Invasive infections due to Candida norvegensis and Candida inconspicua: report of 12 cases and review of the literature. Med Mycol. 2013;51(8):795\u20139.","journal-title":"Med Mycol"},{"issue":"9","key":"4016_CR44","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.jiac.2024.02.014","volume":"30","author":"S Murata","year":"2024","unstructured":"Murata S, Mimura K, Kawamura T, Saito H, Ohno H, Tsujii E, et al. Bloodstream infection caused by Wickerhamiella Pararugosa in a patient with intestinal obstruction: A case report. J Infect Chemother. 2024;30(9):942\u20135.","journal-title":"J Infect Chemother"},{"issue":"1","key":"4016_CR45","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/myc.12703","volume":"61","author":"I Falces-Romero","year":"2018","unstructured":"Falces-Romero I, Cendejas-Bueno E, Romero-Gomez MP, Garcia-Rodriguez J. Isolation of Rhodotorula mucilaginosa from blood cultures in a tertiary care hospital. Mycoses. 2018;61(1):35\u20139.","journal-title":"Mycoses"},{"issue":"3","key":"4016_CR46","doi-asserted-by":"publisher","first-page":"101386","DOI":"10.1016\/j.mycmed.2023.101386","volume":"33","author":"A Spiliopoulou","year":"2023","unstructured":"Spiliopoulou A, Lekkou A, Vrioni G, Leonidou L, Cogliati M, Christofidou M, et al. Fungemia due to rare non-Candida yeasts between 2018 and 2021 in a Greek tertiary care university hospital. J Med Mycol. 2023;33(3):101386.","journal-title":"J Med Mycol"},{"issue":"6","key":"4016_CR47","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1111\/myc.12604","volume":"60","author":"U Roy","year":"2017","unstructured":"Roy U, Jessani LG, Rudramurthy SM, Gopalakrishnan R, Dutta S, Chakravarty C, et al. Seven cases of Saccharomyces fungaemia related to use of probiotics. Mycoses. 2017;60(6):375\u201380.","journal-title":"Mycoses"},{"issue":"1","key":"4016_CR48","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1186\/s12866-024-03506-y","volume":"24","author":"Z Yan","year":"2024","unstructured":"Yan Z, Fu Y, Tan X, Xu L, Ling J, Liu X, et al. Isolate distribution and antifungal susceptibility of Saccharomyces cerevisiae in the National regional medical center of Southwest China for women and children during 2018\u20132023. BMC Microbiol. 2024;24(1):345.","journal-title":"BMC Microbiol"},{"issue":"1","key":"4016_CR49","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1080\/00362177985380091","volume":"17","author":"DL Holzschu","year":"1979","unstructured":"Holzschu DL, Chandler FW, Ajello L, Ahearn DG. Evaluation of industrial yeasts for pathogenicity. Sabouraudia. 1979;17(1):71\u20138.","journal-title":"Sabouraudia"},{"key":"4016_CR50","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.mmcr.2014.10.003","volume":"6","author":"G Scoppettuolo","year":"2014","unstructured":"Scoppettuolo G, Donato C, De Carolis E, Vella A, Vaccaro L, La Greca A, et al. Candida utilis catheter-related bloodstream infection. Med Mycol Case Rep. 2014;6:70\u20132.","journal-title":"Med Mycol Case Rep"},{"issue":"8","key":"4016_CR51","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1111\/myc.12766","volume":"61","author":"R Gaisne","year":"2018","unstructured":"Gaisne R, Jeddi F, Morio F, Le Clerc QC, Hourmant M, Blancho G, et al. Candida utilis fungaemia following endoscopic intervention on ureteral stent in a kidney transplant recipient: case report and a review of the literature. Mycoses. 2018;61(8):594\u20139.","journal-title":"Mycoses"},{"key":"4016_CR52","unstructured":"Singh DP, Verma RK, Yadav RK, Anant K, Das A. Candida utilis as an emerging rare cause of septicemia among neonates and children in Western Uttar Pradesh: A case series. Curr Med Mycol. 2024;10:e2024.345184.1529."},{"issue":"10","key":"4016_CR53","first-page":"000281","volume":"3","author":"TS Sreelekshmi","year":"2021","unstructured":"Sreelekshmi TS, Ninan MM, Premanand A, Chacko A, Sahni RD, Michael JS. Candida utilis: a rare cause of septicemia in children. Access Microbiol. 2021;3(10):000281.","journal-title":"Access Microbiol"},{"issue":"7","key":"4016_CR54","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.cmi.2019.03.026","volume":"25","author":"EC Francisco","year":"2019","unstructured":"Francisco EC, de Almeida Junior JN, de Queiroz Telles F, Aquino VR, Mendes AVA, de Andrade Barberino MGM, et al. Species distribution and antifungal susceptibility of 358 trichosporon clinical isolates collected in 24 medical centres. Clin Microbiol Infect. 2019;25(7):909.e1-.e5.","journal-title":"Clin Microbiol Infect"},{"issue":"9","key":"4016_CR55","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1016\/j.jfma.2020.12.007","volume":"120","author":"SH Kuo","year":"2021","unstructured":"Kuo SH, Lu PL, Chen YC, Ho MW, Lee CH, Chou CH, et al. The epidemiology, genotypes, antifungal susceptibility of trichosporon species, and the impact of voriconazole on trichosporon fungemia patients. J Formos Med Assoc. 2021;120(9):1686\u201394.","journal-title":"J Formos Med Assoc"},{"key":"4016_CR56","doi-asserted-by":"crossref","unstructured":"Guo LN, Yu SY, Hsueh PR, Al-Hatmi AMS, Meis JF, Hagen F et al. Invasive infections due to Trichosporon: species distribution, genotyping, and antifungal susceptibilities from a multicenter study in China. J Clin Microbiol. 2019;57(2).","DOI":"10.1128\/JCM.01505-18"},{"issue":"7","key":"4016_CR57","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1017\/ice.2022.204","volume":"44","author":"A de St Maurice","year":"2023","unstructured":"de St Maurice A, Parti U, Anikst VE, Harper T, Mirasol R, Dayo AJ, et al. Clinical, Microbiological, and genomic characteristics of clade-III Candida auris colonization and infection in Southern California, 2019\u20132022. Infect Control Hosp Epidemiol. 2023;44(7):1093\u2013101.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"7","key":"4016_CR58","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.3201\/eid2907.221888","volume":"29","author":"R Biran","year":"2023","unstructured":"Biran R, Cohen R, Finn T, Brosh-Nissimov T, Rahav G, Yahav D, et al. Nationwide outbreak of Candida auris infections driven by COVID-19 hospitalizations, Israel, 2021\u20132022. Emerg Infect Dis. 2023;29(7):1297\u2013301.","journal-title":"Emerg Infect Dis"},{"issue":"8","key":"4016_CR59","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1080\/00365540410017563","volume":"36","author":"DP Kontoyiannis","year":"2004","unstructured":"Kontoyiannis DP, Torres HA, Chagua M, Hachem R, Tarrand JJ, Bodey GP, et al. Trichosporonosis in a tertiary care cancer center: risk factors, changing spectrum and determinants of outcome. Scand J Infect Dis. 2004;36(8):564\u20139.","journal-title":"Scand J Infect Dis"},{"issue":"4","key":"4016_CR60","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s10096-021-04394-0","volume":"41","author":"M Kutlu","year":"2022","unstructured":"Kutlu M, Sayin-Kutlu S, Alp-Cavus S, Ozturk SB, Tasbakan M, Ozhak B, et al. Mortality-associated factors of candidemia: a multi-center prospective cohort in Turkey. Eur J Clin Microbiol Infect Dis. 2022;41(4):597\u2013607.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"4016_CR61","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/myc.13524","volume":"66","author":"MI Del Principe","year":"2023","unstructured":"Del Principe MI, Seidel D, Criscuolo M, Dargenio M, R\u00e1cil Z, Piedimonte M, et al. Clinical features and prognostic factors of Magnusiomyces (Saprochaete) infections in haematology. A multicentre study of SEIFEM\/Fungiscope. Mycoses. 2023;66(1):35\u201346.","journal-title":"Mycoses"},{"key":"4016_CR62","doi-asserted-by":"crossref","unstructured":"Gil \u00d3, Hern\u00e1ndez-Pab\u00f3n JC, Tabares B, Lugo-S\u00e1nchez C, Firacative C. Rare yeasts in Latin America: uncommon yet meaningful. J Fungi (Basel). 2023;9(7).","DOI":"10.3390\/jof9070747"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-025-04016-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-025-04016-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-025-04016-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T02:19:01Z","timestamp":1751422741000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmicrobiol.biomedcentral.com\/articles\/10.1186\/s12866-025-04016-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4016"],"URL":"https:\/\/doi.org\/10.1186\/s12866-025-04016-1","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,2]]},"assertion":[{"value":"6 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study was approved by the Clinical Research Ethics Committee of Akdeniz University Faculty of Medicine under the number 70904504\/318 (approved date: 30\/05\/2022). As the study was retrospective, data collected from routine analysis and did not involve direct patient intervention, the Clinical Research Ethics Committee of Akdeniz University Faculty of Medicine approved the waiver of informed consent and all data were anonymised prior to analysis. In addition, the principles of the Declaration of Helsinki were followed in the conduct of the study. Clinical trial number: not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"385"}}